First-in-Human Phase I Study of ABBV-838, an Antibody–Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma

1. Vij, R.
2. Nath, R.
3. Afar, D.E.H.
4. Mateos, M.-V.
5. Berdeja, J.G.
6. Raab, M.S.
7. Guenther, A.
8. Martínez-Lopez, J.
9. Jakubowiak, A.J.
10. Leleu, X.
11. Weisel, K.
12. Wong, S.
13. Gulbranson, S.
14. Sheridan, J.P.
15. Reddy, A.
16. Paiva, B.
17. Singhal, A.
18. San-Miguel, J.F.
19. Moreau, P.